Why Maximus Stock Is Surging Despite Market Jitters
Maximus Inc. (MMS) shares are rising due to a strong second-quarter earnings surprise and an elevated full-year adjusted profit outlook. Investors are optimistic about the sustainability of recent performance gains. Additionally, a new $400 million share buyback plan and the company's focus on AI-driven automation tools are contributing to the rally by boosting operating margins and signaling a commitment to profitable growth and capital returns.
Maximus Q1 2026: Revenue Dip, EPS Beat, and AI Efficiency Gains
Maximus reported mixed Q1 2026 financial results with a slight revenue miss at $1.31 billion, but an EPS beat at $2.07 and adjusted EBITDA exceeding forecasts. The company attributed this performance to enhanced operational efficiency and strategic investments in AI and automation. Management reaffirmed full-year revenue guidance and raised adjusted EPS guidance, indicating confidence in continued profitability despite some challenges in state-level contract execution.
A Look At Maximus (MMS) Valuation After Sales Decline And Higher EPS Guidance Driven By Automation And AI
Maximus (MMS) has seen its share price decline despite higher adjusted EPS guidance, with the stock currently down 14.5% over the past month. The company's valuation, according to a "most popular narrative," suggests it is 46% undervalued at $59.36 compared to a fair value of $110 per share. This fair value is based on expectations of moderate top-line growth and increased margins, driven by investments in automation and AI, particularly for complex health and claims processing.
The Top 5 Analyst Questions From Maximus’s Q1 Earnings Call
Maximus reported first-quarter results that led to a positive market reaction, despite a year-on-year revenue decline, with management attributing performance to improved operational efficiency and growing technology investments. The company beat adjusted EPS and EBITDA estimates and raised its full-year EPS guidance. Analyst questions focused on elevated days sales outstanding (DSO), buyback capacity, expansion of SNAP solutions, state revenue declines, margin improvement in different segments, and the VBA contract timeline.
Maximus Drops 5.9% Amid Sector-Wide Selling
Maximus, Inc. experienced a 5.9% drop in its stock price, closing at $57.55, due to a broad sector-wide sell-off impacting specialty business services. The decline occurred without company-specific news, suggesting investors are reassessing the entire sector. Other peers like EXLS, TASK, BR, and CNDT also saw significant losses, indicating broader market sentiment shifts rather than individual company performance issues.
Supporting Veterans through whole health
The partnership between Maximus and the Elizabeth Dole Foundation aims to improve support for military and Veteran caregivers, who provide an estimated $400 billion in unpaid care annually. By employing a human-centered, whole-health approach that integrates policy, technology, and community engagement, the initiative seeks to address challenges like financial strain, emotional exhaustion, and systemic neglect faced by caregivers. The collaboration focuses on integrating caregivers into care teams, leveraging data-driven insights, and aligning with federal policy to enhance caregiver resilience and improve health outcomes for service members and Veterans.
Maximus Q2 Earnings Call Highlights
Maximus (MMS) raised its fiscal 2026 earnings outlook for the second consecutive quarter, citing stronger profitability, operating efficiencies from automation and AI, and increased share repurchases. The government services company reported Q2 revenue of $1.31 billion, meeting expectations, and saw its adjusted EBITDA margin improve to 14.4%. Management attributed margin improvements to technology enhancements and cost discipline, with the company raising its full-year adjusted EBITDA margin and EPS forecasts.
MAXIMUS declares $0.30 dividend
MAXIMUS announced a quarterly dividend of $0.30 per share. The dividend is payable on November 29, 2024, to shareholders of record as of November 15, 2024. The ex-dividend date is November 14, 2024.
Maximus Declines 7.7% Since Beating Q2 Earnings Estimates
Maximus (MMS) reported mixed second-quarter fiscal 2026 results, with earnings beating estimates but revenues missing expectations, leading to a 7.7% stock decline since the earnings release. Despite strong operating margin improvements driven by AI and automation, and a raised fiscal 2026 earnings outlook, the market reacted negatively to the revenue miss and weak revenue guidance. The company highlighted increased traction in AI-enabled offerings and automation initiatives, contributing to improved operating leverage.
Maximus Inc stock hits 52-week low at 60.73 USD
Maximus Inc. stock has fallen to a 52-week low of $60.73, marking a 20.51% decline over the past year. Despite this, InvestingPro analysis suggests the stock is undervalued with a P/E ratio of 9.07 and analyst price targets ranging from $85 to $125. The company recently reported Q2 fiscal year 2026 EPS of $2.07, exceeding expectations, though revenue missed targets, leading to an upward adjustment in guidance.
Maximus Q2 Earnings Call Highlights
Maximus (NYSE: MMS) increased its fiscal 2026 earnings outlook for the second consecutive quarter, driven by stronger profitability due to operating efficiencies from automation and artificial intelligence, and increased capital deployment toward share repurchases. The company reported Q2 revenue of $1.31 billion, meeting expectations, and saw adjusted EPS rise to $2.07. Maximus reiterated its full-year revenue and free cash flow guidance while raising its adjusted EBITDA margin and EPS forecasts, emphasizing the role of technology investments and cost discipline in improving financial performance.
Maximus Q2 Earnings Call Highlights
Maximus raised its fiscal 2026 earnings outlook for the second consecutive quarter, driven by stronger profitability, operating efficiencies from automation and AI, and increased share repurchases. The company reported Q2 revenue of $1.31 billion and an adjusted EBITDA margin of 14.4%, with adjusted EPS rising to $2.07. Maximus reiterated its full-year revenue guidance and free cash flow guidance, while increasing its adjusted EBITDA margin and EPS forecasts, citing technology enhancements and cost discipline as key drivers.
Maximus Inc stock hits 52-week low at 60.73 USD By Investing.com
Maximus Inc. stock has fallen to a 52-week low of $60.73, marking a 20.51% decline over the past year. Despite this, InvestingPro analysis suggests the stock is undervalued with a P/E ratio of 9.07 and analyst price targets ranging from $85 to $125. The company recently reported Q2 FY2026 EPS of $2.07, exceeding expectations, though revenue slightly missed forecasts, leading to an upward adjustment in guidance.
MAXIMUS declares $0.30 dividend
MAXIMUS (MMS) has declared a quarterly dividend of $0.30 per share. This dividend is payable on November 29, 2024, to shareholders of record as of November 15, 2024. The ex-dividend date is November 15, 2024.
Has The Market Mispriced Maximus (MMS) After Its Recent 22.9% Year-To-Date Decline?
Maximus (MMS) has seen a significant 22.9% year-to-date decline and a 10.6% decline over the last year, prompting a valuation analysis. Based on a Discounted Cash Flow (DCF) model and Price-to-Earnings (P/E) ratio comparison, the stock appears undervalued, with the DCF indicating a 72.3% intrinsic discount and the current P/E of 9.74x being well below the Professional Services industry average. The article suggests exploring different valuation "Narratives" on Simply Wall St for varied perspectives on its future value.
Maximus (MMS) shares decline after revenue miss despite earnings beat
The article reports that Maximus (MMS) stock declined following its latest earnings report. The decline occurred despite an earnings beat, as the company missed revenue expectations. This summary is based solely on the provided title and limited information.
The Bull Case For Maximus (MMS) Could Change Following AI-Driven Margins And A New Buyback Plan
Maximus (MMS) reported Q2 results showing increased net income despite lower revenue, attributed to AI-driven efficiency gains. The company also announced a new $400 million share repurchase program, extending its focus on margin improvement and capital returns. This update supports the investment narrative that AI can offset contract and volume swings, potentially impacting the stock's valuation.
Maximus Inc (MMS) Stock Down 3.6% -- Now Undervalued? GF Score: 80/100
Maximus Inc (MMS) shares dropped 3.6% today, marking a 25.2% year-to-date decline, yet GuruFocus indicates the stock is currently undervalued by 33.1% compared to its GF Value™ estimate of $96.00. The company holds a strong GF Score™ of 80/100, primarily due to high profitability, despite lower scores in valuation and momentum. Recent insider buying activity, with $0.3 million in purchases versus $0.1 million in sales, suggests insider confidence in the company's future prospects.
MAXIMUS, Inc. Experiences Valuation Adjustment Amidst Competitive Market Landscape
MAXIMUS, Inc. has adjusted its valuation, now showing a lower P/E ratio of 10 compared to some peers, yet maintaining strong competitive financial metrics. The company demonstrates solid operational efficiency with an EV to EBIT of 9.20, a PEG ratio of 0.24, and high returns on capital and equity. This re-evaluation positions MAXIMUS with an attractive valuation profile within its competitive landscape.
Van Berkom & Associates Inc. Trims Stock Position in Maximus, Inc. $MMS
Van Berkom & Associates Inc. has reduced its stake in Maximus, Inc. (MMS) by 2.7%, now holding 1,130,328 shares valued at approximately $97.6 million, making it their eighth-largest holding. Despite high institutional ownership and some funds increasing their positions, Maximus has seen analyst downgrades to "Hold" and its stock is down 1.6%. The company reported a slight EPS beat but a revenue decline, with mixed insider activity including a CFO share purchase and a director sale.
Q2 2026 Maximus Inc Earnings Call Transcript
This document provides the earnings call transcript for Maximus Inc.'s fiscal Q2 2026. It includes an overview of Maximus Inc. (NYSE:MMS) with key financial metrics and a list of various past earnings call transcripts. The transcript begins with an introduction by James Francis, Vice President of Investor Relations, setting the stage for the conference call.
Maximus (MMS) Margin Improvement To 7% TTM Tests Market Caution On Slower Growth
Maximus (MMS) recently reported Q2 2026 results with US$1.3 billion in revenue and a significant rise in its trailing 12-month net profit margin to 7%, up from 5.6% a year prior. Despite strong past earnings growth, the company faces investor caution due to slower forecasted growth rates for both earnings (8.5% p.a.) and revenue (3.6% p.a.), along with a high debt level. Its P/E ratio of 9.7x is considerably lower than the industry average, creating a tension between its discounted valuation and modest growth outlook.
Maximus, Inc. (NYSE:MMS) Q2 2026 Earnings Call Transcript
Maximus, Inc. reported strong Q2 2026 earnings, beating expectations with an adjusted EPS of $2.07 and revenue of $1.31 billion. The company highlighted the positive impact of technology investments, including AI, on profitability and raised its full-year earnings outlook. Maximus plans increased capital deployment toward share repurchases and continues to focus on federal, defense, national security, and state-level Medicaid and SNAP programs utilizing AI-enabled solutions to enhance efficiency and prevent fraud.
Maximus: Fiscal Q2 Earnings Snapshot
Maximus Inc. (MMS) reported fiscal second-quarter net income of $98.1 million, or $1.80 per share, with adjusted earnings of $2.07 per share, exceeding Wall Street expectations. The government health services provider posted revenue of $1.31 billion, falling short of analyst forecasts. Maximus projects full-year earnings between $8.25 and $8.55 per share and revenue ranging from $5.2 billion to $5.35 billion.
Maximus Reports Fiscal Year 2026 Second Quarter Results
Maximus (NYSE: MMS) reported its financial results for the second quarter of fiscal year 2026, ending March 31, 2026, announcing revenue of $1.31 billion and diluted earnings per share of $1.80. The company raised its adjusted EBITDA margin expectation to approximately 14.2% and increased its adjusted diluted earnings per share forecast to a range between $8.25 and $8.55 for the full fiscal year 2026. Additionally, Maximus announced a $400 million share repurchase program and a quarterly cash dividend of $0.33 per share, attributing improved financial performance to efficiency gains through automation and AI-enabled tools.
Maximus (NYSE:MMS) - Stock Analysis
This Simply Wall St analysis provides a detailed look at Maximus (NYSE:MMS), highlighting that the stock is currently trading 72.3% below its estimated fair value. While revenue declined year-over-year, the company raised its full-year 2026 adjusted EPS guidance, supported by AI gains and a new $400 million share repurchase program, indicating management's confidence despite top-line challenges. Analyst consensus targets suggest the stock is significantly undervalued, and Maximus continues to pay a reliable dividend.
MAXIMUS, INC. 2Q 2026: Revenue $1.31B, EPS $1.8— 10-Q Summary
MAXIMUS, INC. reported second-quarter 2026 financial results, showing a slight decrease in revenue to $1.31 billion from $1.36 billion year-over-year, while net income and diluted EPS increased. The revenue decline was attributed to organic shortfalls and prior divestitures, though gross profit improved. The company aims for specific operating margins in its U.S. Federal and U.S. Services segments, emphasizing efficiency and strategic portfolio adjustments.
Earnings Flash (MMS) Maximus, Inc. Posts Q2 Adjusted EPS $2.07 per Share, vs. FactSet Est of $1.97
Maximus, Inc. (MMS) reported its Q2 adjusted EPS of $2.07 per share, surpassing FactSet's estimate of $1.97. The company's adjusted earnings have risen, although revenue for the fiscal second quarter reportedly fell. Maximus also revised its fiscal 2026 adjusted earnings outlook upwards.
Maximus Q2 FY26 slides: margin gains offset revenue decline
Maximus (NYSE: MMS) reported a 4.1% year-over-year revenue decline in Q2 FY26 to $1.306 billion but an adjusted EBITDA margin expansion of 70 basis points to 14.4%, driven by operational efficiencies and AI investments. The company raised its full-year earnings guidance, signaling confidence in its strategic transformation despite a revenue miss. This performance indicates a focus on profitability and efficiency in the face of revenue headwinds, with key strengths in U.S. Federal Services and continued challenges in international operations.
Maximus Reports Fiscal Year 2026 Second Quarter Results
Maximus reported its financial results for the second quarter of fiscal year 2026, with revenue of $1.31 billion and diluted earnings per share of $1.80. The company raised its adjusted EBITDA margin expectation to approximately 14.2% and its adjusted diluted earnings per share expectation to range between $8.25 and $8.55 for the full fiscal year 2026. Maximus also announced a $400 million share repurchase program and a quarterly cash dividend of $0.33 per share, attributing improved results to efficiency gains from automation and AI-enabled tools.
Maximus Inc reports results for the quarter ended March 31 - Earnings Summary
Maximus Inc has released its earnings summary for the quarter that concluded on March 31. The report was provided by Refinitiv and is a brief update on the company's financial results. Further details would require logging in or creating an account.
Maximus (MMS) Q2 Earnings Beat Estimates
Maximus (MMS) reported Q2 earnings of $2.07 per share, surpassing the Zacks Consensus Estimate of $1.98, representing a +4.55% surprise. However, the company's revenue of $1.31 billion for the quarter ended March 2026 missed the Zacks Consensus Estimate. Despite the earnings beat, the stock currently holds a Zacks Rank #4 (Sell) due to an unfavorable trend in estimate revisions.
Maximus (NYSE: MMS) boosts 2026 outlook and authorizes $400M buyback
Maximus (NYSE: MMS) has raised its fiscal year 2026 earnings outlook, increasing its adjusted EBITDA margin guidance by 20 basis points to approximately 14.2% and its adjusted diluted EPS guidance to $8.25–$8.55. The company also announced a refreshed share repurchase authorization of up to $400 million, after having already repurchased 2.0 million shares for about $151 million. Despite a slight revenue decline in Q2 2026, improved profitability was driven by efficiency gains, including AI-enabled tools.
Maximus: Fiscal Q2 Earnings Snapshot
Maximus Inc. (MMS) reported fiscal second-quarter net income of $98.1 million, or $1.80 per share, with adjusted earnings of $2.07 per share, surpassing Wall Street expectations. However, the company's revenue of $1.31 billion for the period fell short of analysts' forecasts. Maximus provided full-year earnings guidance between $8.25 and $8.55 per share, with revenue projections from $5.2 billion to $5.35 billion.
Maximus beats profit forecast, raises guidance on AI gains
Maximus Inc. reported stronger-than-expected second-quarter adjusted earnings ($2.07 vs. $2.02 analyst consensus), though revenue of $1.31 billion missed estimates. The company raised its full-year adjusted EPS guidance to $8.25-$8.55, citing efficiency gains from AI-enabled automation. Share prices rose 1.6% due to the improved earnings outlook and margin expansion.
Maximus falls on revenue miss despite earnings beat
Maximus Inc. reported mixed second-quarter results, with earnings exceeding analyst expectations but revenue falling short, causing shares to drop 3.05%. Despite the revenue miss, attributed to the absence of specific prior-year contracts, the company raised its full-year earnings guidance and adjusted EBITDA margin, citing efficiency gains from AI and automation. Additionally, the Board authorized a $400 million share repurchase program and declared a dividend.
Earnings Flash (MMS) Maximus, Inc. Reports Q2 Revenue $1.31B, vs. FactSet Est of $1.32B
Maximus, Inc. (MMS) reported its second-quarter revenue of $1.31 billion, falling slightly short of the FactSet estimate of $1.32 billion. Despite this, the company's Q2 adjusted earnings per share rose to $2.07, exceeding the FactSet estimate of $1.97. Maximus also increased its fiscal year 2026 adjusted earnings outlook, indicating a positive revision despite the revenue miss.
Maximus: Fiscal Q2 Earnings Snapshot
Maximus Inc. reported strong fiscal second-quarter net income of $98.1 million, or $2.07 per share adjusted for amortization, exceeding Wall Street expectations. While revenue reached $1.31 billion, it slightly missed analyst forecasts. The company provided a full-year earnings outlook of $8.25 to $8.55 per share on revenue between $5.2 billion and $5.35 billion.
Maximus Reports Fiscal Year 2026 Second Quarter Results
Maximus (NYSE: MMS) announced its fiscal year 2026 second quarter results, reporting revenue of $1.31 billion and diluted earnings per share of $1.80. The company raised its adjusted EBITDA margin expectation to approximately 14.2% and adjusted diluted earnings per share to a range of $8.25 to $8.55 for the full fiscal year. Maximus also authorized a $400 million share repurchase program and declared a quarterly cash dividend of $0.33 per share.
Maximus earnings on deck after federal contract delays hit revenue
Maximus Inc. is set to report fiscal second-quarter earnings, with investors keenly watching for signs of recovery from federal contract delays that impacted first-quarter revenue. Analysts expect sequential improvement in earnings per share and revenue, but estimates have seen recent declines. Despite near-term uncertainty, analysts maintain a "buy" rating with significant price upside, while the market has priced in skepticism given its low forward P/E ratio.
Maximus Inc (MMS)
This article provides a brief overview of Maximus Inc. (MMS). No specific details or financial data are included in this very short piece.
Assessing Maximus (MMS) Valuation After Recent Share Price Weakness
This article analyzes Maximus (MMS) stock after recent share price weakness, noting its flat performance over the past year despite a 30.56% decline in the last 90 days. It highlights a common narrative valuing the stock at $110, suggesting it's 40.4% undervalued, driven by investments in digital transformation and expected earnings growth. The article advises investors to weigh both optimistic and concerning factors before making investment decisions.
Comerica Bank Acquires 33,973 Shares of Maximus, Inc. $MMS
Comerica Bank significantly increased its stake in Maximus, Inc. by 124.4%, acquiring an additional 33,973 shares to hold a total of 61,284 shares valued at $5.29 million. Institutional investors now own 97.21% of Maximus. The company also announced a quarterly dividend of $0.33 per share, while analysts have trimmed ratings to a "Hold" consensus.
Maximus Names Elizabeth Moellering General Counsel Shaping Contract And Risk Focus
Maximus (NYSE:MMS) has appointed Elizabeth Moellering as its new General Counsel and Corporate Secretary, a move seen as significant due to her extensive background in litigation and the company's reliance on complex government contracts. Her appointment is expected to influence Maximus's approach to contract risk, compliance, and governance, which could lead to a more cautious stance on high-risk contracts. Investors should monitor how this new legal leadership impacts the company's disclosure practices and risk management strategies amidst its ongoing transformation efforts.
Vanguard Capital Management (NYSE: MMS) reports 5.23% stake in Maximus
Vanguard Capital Management has reported a 5.23% passive ownership stake in Maximus (NYSE: MMS), holding 2,857,086 shares of Common Stock. This disclosure was made via a Schedule 13G SEC filing, signed on April 30, 2026, indicating that Vanguard has sole voting power over 419,450 shares and sole dispositive power over the entire 2,857,086 shares. The filing clarifies that this is a passive investment and does not signal an intent to influence management or control the company.
Why Maximus (MMS) is a Great Dividend Stock Right Now
Maximus (MMS) is highlighted as an attractive dividend stock with a current yield of 2.02%, significantly higher than its industry and the S&P 500 average. The company has a low payout ratio of 16% and is projected to see a nearly 15% increase in earnings for the fiscal year 2026, indicating strong potential for future dividend growth. This makes MMS a compelling choice for income investors.
Vanguard (MMS) discloses 3.52M-share stake, 6.45% ownership
Vanguard Portfolio Management has disclosed a significant stake in Maximus Inc (MMS) through a Schedule 13G SEC filing. The filing indicates that Vanguard beneficially owns 3,523,165 shares of Maximus common stock, representing 6.45% of the class as of March 31, 2026. This ownership is held on behalf of multiple Vanguard-managed accounts and funds, with Vanguard exercising sole dispositive power over these shares.
MAXIMUS (NYSE: MMS) GC Moellering discloses 5,044-share initial stake and RSUs
MAXIMUS General Counsel and Corporate Secretary Elizabeth Moellering has reported an initial direct holding of 5,044.166 shares of common stock. Additionally, her Form 3 filing details several restricted stock unit (RSU) grants from 2024 and 2025, which vest ratably over four years and include dividend equivalent rights. These disclosures provide transparency regarding her initial ownership and future equity compensation in the company.
MMS: A Pick Backed by Stability, Scale, and Strategic Expansion
Maximus Inc. (MMS) is presented as an attractive investment due to its strong presence in government health and human services, consistent cash generation, and a reliable contract-driven business model. While it may not offer explosive growth, its stability, predictable revenues, and long-term demand drivers, coupled with a commitment to shareholder returns through dividends, make it suitable for investors prioritizing steady compounding. The article also touches on various risks, including slowing growth, reliance on government contracts, competition, and regulatory changes, ultimately recommending it as a "Buy With Awareness."
Maximus Taps Elizabeth Moellering as General Counsel
Maximus has appointed Elizabeth Moellering as its new general counsel and corporate secretary, succeeding John Martinez. Moellering, who joined Maximus in 2024, previously served as interim general counsel and deputy general counsel. Bruce Caswell, Maximus president and CEO, highlighted her strong judgment and collaborative leadership as key assets for the role.
